PrECOG
@precogonc
Innovative cancer research studies developed through industry partnerships and networks. Supporting @eaonc's efforts to advance cancer care
ID: 1055796343820697600
http://www.PrECOGLLC.org 26-10-2018 12:20:38
521 Tweet
195 Takipçi
530 Takip Edilen
ICYMI: PrE0403 manuscript published in Blood Journal by Dr. Portell UVA Cancer Center and team. Learn about this phase II study of #venetoclax added to bendamustine and obinutuzumab in patients w/ high-risk follicular #Lymphoma as front-line therapy here: rdcu.be/elII2